Nutra Pharma Corp.
NPHC
$0.00
$0.000.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.40M | -230.90K | -260.70K | -367.10K | -426.90K |
| Total Depreciation and Amortization | 24.10K | 23.40K | 23.00K | 22.60K | 22.20K |
| Total Amortization of Deferred Charges | 57.20K | 24.10K | 34.40K | 38.10K | 37.50K |
| Total Other Non-Cash Items | 1.01M | 49.90K | 58.10K | 75.60K | 60.00K |
| Change in Net Operating Assets | -93.80K | -44.80K | 164.20K | 137.30K | 136.10K |
| Cash from Operations | -405.00K | -178.20K | 19.10K | -93.60K | -171.20K |
| Capital Expenditure | -26.10K | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 8.30K | 34.00K | -1.00K | -- |
| Cash from Investing | -26.10K | 8.30K | 34.00K | -1.00K | -- |
| Total Debt Issued | 574.90K | 338.60K | 131.60K | 195.30K | 306.40K |
| Total Debt Repaid | -166.50K | -132.20K | -184.70K | -100.60K | -135.20K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 408.50K | 206.40K | -53.10K | 94.60K | 171.20K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -22.60K | 36.40K | -- | -- | -- |